AAD: Glaucoma Drug Boosts Eyelash Growth
SAN FRANCISCO (MedPage Today) — Patients with skimpy eyelashes experienced significant growth and thickening when they applied bimatoprost (Latisse), an ophthalmic solution normally used to treat glaucoma, according to a randomized clinical trial reported here. (Source: MedPage Today Dermatology) MedWorm Message: Register for MedMatcha, MedWorm’s medical advertising network , and receive $5 free advertising
Continued here:
AAD: Glaucoma Drug Boosts Eyelash Growth
Allergan Announces U.S. Food and Drug Administration (FDA) Approval of Latisse — First and Only Treatment Approved by the FDA for Hypotrichosis of…
IRVINE, Calif.–(BUSINESS WIRE)–Dec 26, 2008 – Allergan, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Latisse (bimatoprost ophthalmic solution) 0.03% as a novel treatment for hypotrichosis of the eyelashes.
